E-LIB Suche - Ergebnisse für: Beard, Helen

1

Superior outcomes in neuroretina following IV versus intra-..:

Hemsley, Kim M. ; Winner, Leanne ; Shoubridge, Andrew...
Molecular Genetics and Metabolism. 141 (2024) 2 - p. 107877 , 2024

Link: https://doi.org/10.1016/..

2

A prohibitin-targeting drug modifies aspects of disease in ..:

Hemsley, Kim M. ; Beard, Helen ; Doherty, Gareth G....
Molecular Genetics and Metabolism. 138 (2023) 2 - p. 107145 , 2023

Link: https://doi.org/10.1016/..

3

Repetitive, non-invasive imaging of neurodegeneration, and ..:

Hemsley, Kim M. ; Beard, Helen ; Chidlow, Glyn...
Experimental Neurology. , 2023

Link: https://doi.org/10.1016/..

4

The ovine Type II Gaucher disease model recapitulates aspec..:

Winner, Leanne K. ; Beard, Helen ; Karageorgos, Litsa...
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869 (2023) 4 - p. 166658 , 2023

Link: https://doi.org/10.1016/..

5

Is SGSH heterozygosity a risk factor for early‐onset neurod..:

Douglass, Meghan L. ; Beard, Helen ; Shoubridge, Andrew...
Journal of Inherited Metabolic Disease. 44 (2021) 3 - p. 763-776 , 2021

Link: https://doi.org/10.1002/..

6

AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice ..:

Hocquemiller, Michaël ; Hemsley, Kim M. ; Douglass, Meghan L....
Molecular Therapy - Methods & Clinical Development. 17 (2020) - p. 174-187 , 2020

Link: https://doi.org/10.1016/..

7

Is the eye a window to the brain in Sanfilippo syndrome?:

Beard, Helen ; Chidlow, Glyn ; Neumann, Daniel...
Acta Neuropathologica Communications. 8 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

8

Axonal dystrophy in the brain of mice with Sanfilippo syndr..:

Beard, Helen ; Hassiotis, Sofia ; Gai, Wei-Ping...
Experimental Neurology. 295 (2017) - p. 243-255 , 2017

Link: https://doi.org/10.1016/..

9

A novel conditional Sgsh knockout mouse model recapitulates..:

Lau, Adeline A. ; King, Barbara M. ; Thorsen, Carly L....
Journal of Inherited Metabolic Disease. 40 (2017) 5 - p. 715-724 , 2017

Link: https://doi.org/10.1007/..

10

Low‐dose, continuous enzyme replacement therapy ameliorates..:

King, Barbara ; Hassiotis, Sofia ; Rozaklis, Tina...
Journal of Neurochemistry. 137 (2016) 3 - p. 409-422 , 2016

Link: https://doi.org/10.1111/..

11

Delivery of therapeutic protein for prevention of neurodege..:

Marshall, Neil R. ; Hassiotis, Sofia ; King, Barbara...
Experimental Neurology. 263 (2015) - p. 79-90 , 2015

Link: https://doi.org/10.1016/..

12

Determination of the role of injection site on the efficacy..:

Beard, Helen ; Luck, Amanda J. ; Hassiotis, Sofia...
Molecular Genetics and Metabolism. 115 (2015) 1 - p. 33-40 , 2015

Link: https://doi.org/10.1016/..

13

Evaluation of enzyme dose and dose‐frequency in amelioratin..:

King, Barbara ; Marshall, Neil ; Beard, Helen...
Journal of Inherited Metabolic Disease. 38 (2014) 2 - p. 341-350 , 2014

Link: https://doi.org/10.1007/..

14

Disease stage determines the efficacy of treatment of a pae..:

Hassiotis, Sofia ; Beard, Helen ; Luck, Amanda...
European Journal of Neuroscience. 39 (2014) 12 - p. 2139-2150 , 2014

Link: https://doi.org/10.1111/..

15

Helper-dependent canine adenovirus vector-mediated transgen..:

Lau, Adeline A. ; Rozaklis, Tina ; Ibanes, Sandy...
Gene. 491 (2012) 1 - p. 53-57 , 2012

Link: https://doi.org/10.1016/..